Skip to main content

Therapeutics

Therapeutics

BrainStorm Cancer Therapeutics: Redefining Blood-Brain Barrier Penetration

Discovery and Optimization of Novel Compounds Targeting Programmed Ribosomal Frameshifting in RNA Viruses

Pastorus: Developing the First Drug for Core Symptoms of Autism

Development of camostat-related compounds for COVID-19 and other coronavirus infections

Direct intralesional mTOR inhibition for targeted treatment of sporadic and syndromic venous and lymphatic malformations

Stilbene a new antibiotic class for topical and systemic administration

Fyn & Pyk2 Kinase Inhibition for Alzheimer's Disease

Target Site Blocker (TSB) of the IL-17A-miR466I-3p iInteraction Prevents Progressive and Relapsing Remitting EAE

NCS1 - A New Target for Mood Disorders and Wolfram Syndrome

Subscribe to Therapeutics